Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.02
35% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.9K | $218.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $19.5K | $1.6M | $14.5K | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $18.4K | −$1.4M | −$14.5K | $0 | $0 | $0 | $0 | $0 |
| Gross margin | 48.6% | -648.5% | — | — | — | — | — | — |
| R&D | $124.0K | $4.8K | $0 | $59.5K | $26.9K | $23.1K | $9 | $3.0K |
| Operating income | −$4.5M | −$3.2M | −$529.8K | −$355.0K | −$263.0K | −$220.0K | −$168.7K | −$181.9K |
| EBITDA | −$4.2M | −$3.4M | −$529.8K | −$341.3K | −$270.6K | −$12.2K | $252.5K | −$181.9K |
| Net income | −$4.5M | −$3.5M | −$591.2K | −$356.3K | −$282.0K | −$228.0K | $263 | −$86.3K |
| Net margin | -11918.9% | -1591.0% | — | — | — | — | — | — |
| EPS (diluted) | -0.93 | -0.65 | -0.11 | -0.05 | -0.03 | -0.02 | 0.02 | -0.01 |
Annual figures · source: Financial Modeling Prep
NANOSPHERE HLTH SCIENCES
No one on the platform currently holds NSHSF.
No tracked institution reports a position in NSHSF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-07-07 | 1-for-20reverse |
No one on the platform has traded NSHSF yet.
| $4M |
| — |
| CPMVMosaic ImmunoEngineering Inc. | $0.67 | +0.00% | $5M | — |
| CUBTCurative Biotechnology, Inc. | $1.20 | +32.23% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.